Literature DB >> 16606781

Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.

E M Frohman1, E Havrdova, F Lublin, F Barkhof, A Achiron, M K Sharief, O Stuve, M K Racke, L Steinman, H Weiner, M Olek, R Zivadinov, J Corboy, C Raine, G Cutter, J Richert, M Filippi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16606781     DOI： 10.1001/archneur.63.4.614

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  19 in total

1.  Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.

Authors:  Antoine Philippe Fournier; Aurélien Quenault; Sara Martinez de Lizarrondo; Maxime Gauberti; Gilles Defer; Denis Vivien; Fabian Docagne; Richard Macrez
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

Review 2.  Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.

Authors:  M P Kurnellas; K C Donahue; S Elkabes
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

3.  Optic Neuritis: The Role of Disease-modifying Therapy in This Clinically Isolated Syndrome.

Authors:  Fiona Costello
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

4.  Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.

Authors:  A J Ligocki; W H Rounds; E M Cameron; C T Harp; E M Frohman; A M Courtney; S Vernino; L G Cowell; B Greenberg; N L Monson
Journal:  Genes Immun       Date:  2013-04-18       Impact factor: 2.676

5.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

6.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Authors: 
Journal:  Arch Neurol       Date:  2008-06

7.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04

Review 8.  Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Authors:  Timothy Vollmer; Lynn Huynh; Caroline Kelley; Philip Galebach; James Signorovitch; Allitia DiBernardo; Rahul Sasane
Journal:  Neurol Sci       Date:  2015-11-04       Impact factor: 3.307

9.  Clinical predictors of early second event in patients with clinically isolated syndrome.

Authors:  Ellen M Mowry; Mila Pesic; Barbara Grimes; Serina R Deen; Peter Bacchetti; Emmanuelle Waubant
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

Authors:  Georgina Arrambide; Carmen Espejo; Jennifer Yarden; Ella Fire; Larissa Spector; Nir Dotan; Avinoam Dukler; Alex Rovira; Xavier Montalban; Mar Tintore
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.